-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. … It also allows one to evaluate the tradeoff in benefits, harms, and costs of different test-and treat … Evaluate previous modeling studies. … Fourth, evaluate previous modeling studies. … Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. … It also allows one to evaluate the tradeoff in benefits, harms, and costs of different test-and treat … Evaluate previous modeling studies. … Fourth, evaluate previous modeling studies. … Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.
-
effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
October 01, 2007 - Objective: To develop and evaluate a new real-time surveillance
system that uses dynamic data files and … avoidable delays between the first reports of a potential
adverse event and the studies that formally evaluate … In this analysis, we evaluate 2 outcomes that meet all
the above criteria: Guillain-Barre syndrome and … Example of signal detection using maximized se-
quential probability ratio testing to evaluate historical … Changes in LLRs in the analysis of meningococcal
conjugate vaccine using concurrent controls to evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
January 01, 2009 - Phase 0 studies are exploratory first-in-human trials to evaluate
whether the drug or agent behaves … In
1978, Freedman classified designs to evaluate and compare imaging techniques and observed a
parallel … It is inevitable that such trials evaluate the effectiveness of
testing as well as that of downstream … How to
evaluate a diagnostic marker test. … When is
measuring sensitivity and specificity
sufficient to evaluate a diagnostic test, and
when do
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
January 01, 2009 - Phase 0 studies are exploratory first-in-human trials to evaluate
whether the drug or agent behaves … In
1978, Freedman classified designs to evaluate and compare imaging techniques and observed a
parallel … It is inevitable that such trials evaluate the effectiveness of
testing as well as that of downstream … How to
evaluate a diagnostic marker test. … When is
measuring sensitivity and specificity
sufficient to evaluate a diagnostic test, and
when do
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol.pdf
January 01, 2020 - We will primarily evaluate studies that
directly compare alternative regimens but will also attempt … For KQ 3, we will
also evaluate, timing with respect to delivery and subgroups with obesity or reduced … As described
below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also
evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will
evaluate each
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
April 20, 2022 - We will primarily evaluate studies that
directly compare alternative regimens but will also attempt … For KQ 3, we will
also evaluate, timing with respect to delivery and subgroups with obesity or reduced … As described
below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also
evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will
evaluate each
-
effectivehealthcare.ahrq.gov/products/methods-decision-simulation-modeling/research
February 22, 2013 - recent efforts to use modeling with a systematic review to update USPSTF cancer screening guidelines, to evaluate … the process of conducting a simultaneous systematic review and modeling exercise, and to evaluate stakeholder-perceived
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/routine-antenatal-care.pdf
January 01, 2020 - We will evaluate outcomes as
listed in the Study Eligibility Criteria Table. … As described
below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also
evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will
evaluate each … We will also evaluate the adequacy of
descriptions of study participants, interventions, outcomes, and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
January 01, 2020 - We will evaluate outcomes as
listed in the Study Eligibility Criteria Table. … As described
below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also
evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will
evaluate each … We will also evaluate the adequacy of
descriptions of study participants, interventions, outcomes, and
-
effectivehealthcare.ahrq.gov/products/schedule-visits-antenatal-care/protocol
August 06, 2021 - We will evaluate outcomes as listed in the Study Eligibility Criteria Table. … As described below, we will evaluate the strength of evidence (SoE) for these outcomes. … We may also evaluate SoE for other included outcomes. … Assessment of Quality and/or Methodological Risk of Bias of Individual Studies: We will evaluate each … We will also evaluate the adequacy of descriptions of study participants, interventions, outcomes, and
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/cervical-degenerative-disease
June 11, 2021 - The purpose of this topic nomination is to evaluate all available evidence, from which, the Congress … extensively in certain areas will be asked to recuse themselves from voting and will be assigned to evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
December 01, 2020 - • No studies evaluate instruments for predicting risk of opioid misuse, opioid use
disorder or overdose … , or evaluate risk mitigation strategies to be used when
prescribing opioids for episodic migraine … inability to capture such harms is due to study design as the
5
majority of trials evaluate … The trials we analyzed did not sufficiently evaluate these
potential combination therapies and their
-
effectivehealthcare.ahrq.gov/sites/default/files/s1.pdf
October 01, 2007 - Furthermore, premarketing studies
are generally not designed to evaluate multiple endpoints, detect rare … adverse effects,
evaluate health outcomes over long periods, or compare all treatment options available … The program is comprised
of 3 components that work collaboratively to evaluate, synthesize, develop,
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
December 01, 2021 - KQ3: Evaluate the effect of nutritional interventions on symptoms associated w ith cancer
treatment, … KQ4: Evaluate the effect of interventions intended for w eight loss prior to or during treatment in … For our contextual question, we will evaluate all studies included in KQ1-4 that include
discussions … When data allow, we also will perform stratified analyses to evaluate
a priori subgroups (from Table … For outcomes found to have at least moderate
or high strength of evidence, we will evaluate reporting
-
effectivehealthcare.ahrq.gov/products/restless-legs/research-protocol
December 16, 2011 - We will evaluate methods used to define RLS, assess its severity, and measure treatment benefits and … Studies that evaluate only acute effects (< 4 weeks) of treatment. … Inclusion/Exclusion criteria for observational studies (for Key Question 2):
Studies that evaluate … To evaluate harms of interest, we will include evidence from case reports or case series. … We will exclude observational studies that do not evaluate harms from treatments for RLS.
B.
-
effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-abelson-2.pdf
January 11, 2017 - o To evaluate policy options?
Slide 28
How will deliberation outputs be synthesized?
-
effectivehealthcare.ahrq.gov/products/survival-quality/research
April 12, 2013 - Common study limitations included significant data missing not at random, failure to evaluate patient-reported … There is a need for prospective research to evaluate: (1) any causal relationship between patient knowledge
-
effectivehealthcare.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
January 01, 2012 - Evaluate the peer-‐review comments and revise the draft guidelines
9. … Continue to evaluate the guidelines and revise them
further if needed
Slide 3: Prostate Cancer Advisory
-
effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_synthesizingoutputs.pdf
May 18, 2012 - -To evaluate policy options?
2
How will deliberation outputs be
synthesized?